Impact des traitements initiés à l'urgence pour les patients victimes d'un traumatisme cranio-cérébral léger

 

Jocelyn Gravel

Centre de recherche du CHU Ste-Justine

 

Domaine : santé de la mère, des enfants et des adolescents 

Programme consortium pour le développement de la recherche en traumatologie - volet 4

Concours 2012-2013

Partenaires

Ministère de la Santé et des Services sociaux
Société de l'assurance automobile du Québec
Réseau privincial de recherche en adaptation-réadaptation
Association québécoise d'établissements de santé et de services sociaux
Associtation des établissements de réadaptation en déficience physique du Québec

Issues surrounding mild Traumatic Brain Injury (mTBI), generally known as "concussion", have been the subject of much media attention recently. Recent studies report that 6 out of 1,000 people are victims of mTBI each year. Mild TBI constitutes a problem of such magnitude that provincial and international organisations have recently made a strong case for the urgency of improved approaches to their management, calling mild TBI "a silent epidemic" and "a serious public health problem". Also, studies have suggested that the majority of patients with mTBI suffer from recurrent symptoms (headache, attention deficit, etc.) one week following the injury and that some will have long-term sequelae. These symptoms have significant health, social and economic repercussions.

To our knowledge, there has been no systematic review of the medical literature to evaluate the impact of treatments provided in the emergency department for patients suffering from mTBI.

The primary objective of our study is to perform a complete review of the medical literature identifying treatments provided or initiated in the emergency department to improve outcomes in the short term (1 week), mid term (one month) or long term (more than 3 months) for patients who suffer mTBI. This review will evaluate treatments for children and adults.

Our study will identify treatments available and useful in the acute phase to decrease symptoms secondary to mTBI.